CureAge Therapeutics

About CureAge Therapeutics

CureAge Therapeutics is a pre-clinical gene therapy company focused on curing peripheral nerve diseases, with an initial emphasis on Neurofibromatosis type 1 (NF1). The company is developing a lipid nanoparticle (LNP) platform aimed at delivering next-generation genetic payloads specifically to peripheral nerve tissue. Co-founded with Deep Science Ventures and the Children’s Tumor Foundation, CureAge Therapeutics maintains a strong connection with NF families.

Career Opportunities

CureAge Therapeutics offers a unique opportunity for professional growth as part of a small, highly motivated founding team. Employees can expect a dynamic working environment where they can significantly influence the company’s scientific vision and culture.

• Be part of the core team and shape the company’s direction.
• Lead research initiatives in a world-class pre-clinical environment.
• Engage in meaningful work that directly impacts patients with NF1.